TEMPUS AI INC-CL A (1TEM.MI) Stock Price & Overview
BIT:1TEM • US88023B1035
Current stock price
The current stock price of 1TEM.MI is 46.125 EUR. Today 1TEM.MI is up by 24.36%.
1TEM.MI Key Statistics
- Market Cap
- 8.246B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.52
- Dividend Yield
- N/A
1TEM.MI Stock Performance
1TEM.MI Stock Chart
1TEM.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1TEM.MI.
1TEM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1TEM.MI. The financial health of 1TEM.MI is average, but there are quite some concerns on its profitability.
1TEM.MI Earnings
On February 24, 2026 1TEM.MI reported an EPS of -0.04 and a revenue of 367.21M. The company beat EPS expectations (5.3% surprise) and beat revenue expectations (0.36% surprise).
1TEM.MI Forecast & Estimates
23 analysts have analysed 1TEM.MI and the average price target is 70.56 EUR. This implies a price increase of 52.97% is expected in the next year compared to the current price of 46.125.
For the next year, analysts expect an EPS growth of 30.29% and a revenue growth 25.72% for 1TEM.MI
1TEM.MI Groups
Sector & Classification
1TEM.MI Financial Highlights
Over the last trailing twelve months 1TEM.MI reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS increased by 75.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.77% | ||
| ROE | -49.87% | ||
| Debt/Equity | 2.52 |
1TEM.MI Ownership
1TEM.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| DIM | SARTORIUS STEDIM BIOTECH | 35.67 | 17.734B | ||
| 56S1 | SARTORIUS STEDIM BIOTECH | 35.3 | 17.695B | ||
| SRT3 | SARTORIUS AG-VORZUG | 40.36 | 17.073B | ||
| SRT | SARTORIUS AG | 31.53 | 13.314B | ||
| QIA | QIAGEN N.V. | 15.96 | 7.212B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.92 | 2.247B | ||
| EVT | EVOTEC SE | N/A | 990.792M | ||
| GXI | GERRESHEIMER AG | 8.41 | 730.176M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 14.88 | 198.54M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 158M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1TEM.MI
Company Profile
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Info
IPO: 2025-05-30
TEMPUS AI INC-CL A
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 3800
Phone: 18335144187
TEMPUS AI INC-CL A / 1TEM.MI FAQ
What does 1TEM do?
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
What is the stock price of TEMPUS AI INC-CL A today?
The current stock price of 1TEM.MI is 46.125 EUR. The price increased by 24.36% in the last trading session.
Does 1TEM stock pay dividends?
1TEM.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1TEM stock?
1TEM.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for 1TEM.MI stock?
23 analysts have analysed 1TEM.MI and the average price target is 70.56 EUR. This implies a price increase of 52.97% is expected in the next year compared to the current price of 46.125.
Is TEMPUS AI INC-CL A (1TEM.MI) expected to grow?
The Revenue of TEMPUS AI INC-CL A (1TEM.MI) is expected to grow by 25.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the ownership details for 1TEM stock?
You can find the ownership structure of TEMPUS AI INC-CL A (1TEM.MI) on the Ownership tab.